Divi's Laboratories Ltd
NSE:DIVISLAB
Divi's Laboratories Ltd
NSE:DIVISLAB
Price:
3 894.3999 INR
-1.35%
Updated:
May 7, 2024
Divi's Laboratories Ltd
Cash from Financing Activities
|
Divi's Laboratories Ltd
Cash from Financing Activities Peer Comparison
Comparables:
SUVEN
DCAL
SYNGENE
TARSONS
I
INNOVACAP
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Divi's Laboratories Ltd
NSE:DIVISLAB
|
Cash from Financing Activities
-₹8B
|
CAGR 3-Years
10%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
|
|
Suven Life Sciences Ltd
NSE:SUVEN
|
Cash from Financing Activities
₹4B
|
CAGR 3-Years
420%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Dishman Carbogen Amcis Ltd
NSE:DCAL
|
Cash from Financing Activities
₹1.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Syngene International Ltd
NSE:SYNGENE
|
Cash from Financing Activities
-₹3.2B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Tarsons Products Ltd
NSE:TARSONS
|
Cash from Financing Activities
₹845.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
I
|
Innova Captab Ltd
NSE:INNOVACAP
|
Cash from Financing Activities
₹270.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Divi's Laboratories Ltd's Cash from Financing Activities?
Cash from Financing Activities
-8B
INR
-8B
INR
Based on the financial report for Mar 31, 2023, Divi's Laboratories Ltd's Cash from Financing Activities amounts to -8B INR.
What is Divi's Laboratories Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-20%
-20%
Over the last year, the Cash from Financing Activities growth was -50%. The average annual Cash from Financing Activities growth rates for Divi's Laboratories Ltd have been 10% over the past three years , -20% over the past five years .
You don't have any saved screeners yet
